Imaging Matrix-Assisted Laser Desorption/Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry of oxaliplatin derivatives in human tissue sections.

HIPEC Isotopic fine structure MALDI-FTICR Mass spectrometry imaging Ovary Platinum metabolites

Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
15 Jan 2022
Historique:
received: 08 06 2021
revised: 17 09 2021
accepted: 29 09 2021
entrez: 5 11 2021
pubmed: 6 11 2021
medline: 9 11 2021
Statut: ppublish

Résumé

Mass Spectrometry Imaging is an effective technology that allows to determine the in-situ distribution of endogen and/or exogen small molecules. It is a rapidly emerging approach for visualizing drugs and their metabolites within biological tissues. Matrix-Assisted Laser Desorption Ionization (MALDI) Mass Spectrometry Imaging (MSI) coupled to high resolving power analyzer (e.g. TOF) was already investigated for metallodrug localization and metabolization studies, but was proved to suffer from a lack of sensitivity and resolution, leading to poor coverage and assignment. To counter these technological limitations, the use of ultra-high resolving power analyzer such as Fourier Transform Ion Cyclotron Resonance (FTICR) could be revealed as a technique of choice. The high field FTICR MS provides ultra-high resolving power and mass accuracy that allows exhaustive molecule coverage and non-ambiguous molecular formula assignments. Platinum derivatives, such as oxaliplatin, are widely used as therapeutic agents for cancer treatment. The assessment of their intake, distribution and metabolism within the organs is important to know the risks associated with their use. In this study, MALDI FTICR MSI analyses were performed to better understand the penetration and metabolization of platinum derivatives in ovaries of women treated by Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for peritoneal metastasis of colorectal or appendicular origin. Twelve ovary sections, from six ovary samples in six women donors, before and after treatment, were analyzed with 120 μm spatial resolution. For the first time, the high resolving power (220,000 at m/z 457) and sub-ppm accuracy (<1 ppm) of the FTICR combined with an Isotopic Fine Structure study enabled to distinguish two Pt-isobaric species derived from oxaliplatin in biological tissues. One of these, which is unknown, was specifically localized at the contour of the ovary.

Identifiants

pubmed: 34736651
pii: S0039-9140(21)00837-7
doi: 10.1016/j.talanta.2021.122915
pii:
doi:

Substances chimiques

Oxaliplatin 04ZR38536J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122915

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Justine Ferey (J)

Normandie Univ, COBRA, UMR 6014 and FR 3038, Université de Rouen, INSA de Rouen, CNRS, IRCOF, 1 rue Tesnières, 76821, Mont-Saint-Aignan, Cedex, France; UMR1331 Toxalim (Research Centre in Food Toxicology), Toulouse University, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France; Metatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, 31027, Toulouse, France.

Marion Larroque (M)

Unité de Recherche Translationnelle, Institut du Cancer de Montpellier (ICM), 208 rue des apothicaires, 34298, Montpellier, France.

Isabelle Schmitz-Afonso (I)

Normandie Univ, COBRA, UMR 6014 and FR 3038, Université de Rouen, INSA de Rouen, CNRS, IRCOF, 1 rue Tesnières, 76821, Mont-Saint-Aignan, Cedex, France. Electronic address: isabelle.schmitz-afonso@univ-rouen.fr.

Johann Le Maître (J)

Normandie Univ, COBRA, UMR 6014 and FR 3038, Université de Rouen, INSA de Rouen, CNRS, IRCOF, 1 rue Tesnières, 76821, Mont-Saint-Aignan, Cedex, France.

Olivia Sgarbura (O)

Service Chirurgie, Institut du Cancer de Montpellier (ICM), 208 rue des apothicaires, 34298, Montpellier, France.

Sébastien Carrere (S)

Service Chirurgie, Institut du Cancer de Montpellier (ICM), 208 rue des apothicaires, 34298, Montpellier, France.

François Quenet (F)

Service Chirurgie, Institut du Cancer de Montpellier (ICM), 208 rue des apothicaires, 34298, Montpellier, France.

Brice Bouyssiere (B)

Universite de Pau et des Pays de l'Adour, E2S UPPA, CNRS, IPREM, Institut des Sciences Analytiques et de Physico-chimie pour l'Environnement et les Materiaux, UMR5254, Hélioparc, 64053, Pau, France.

Christine Enjalbal (C)

Université Montpellier, IBMM, CNRS, ENSCM, 34095, Montpellier, France.

Sandra Mounicou (S)

Universite de Pau et des Pays de l'Adour, E2S UPPA, CNRS, IPREM, Institut des Sciences Analytiques et de Physico-chimie pour l'Environnement et les Materiaux, UMR5254, Hélioparc, 64053, Pau, France.

Carlos Afonso (C)

Normandie Univ, COBRA, UMR 6014 and FR 3038, Université de Rouen, INSA de Rouen, CNRS, IRCOF, 1 rue Tesnières, 76821, Mont-Saint-Aignan, Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH